[Role of cardiologists in control of risk factors and prescription of secondary-preventive drugs in elderly patients with atherosclerotic cardiovascular disease. The French ELIAGE-MG survey].
Little information is available as regards risk factor control and use of secondary prevention medications in elderly populations with documented atherosclerotic disease. The ELIAGE-MG survey included 3247 patients with cardiovascular disease seen in ambulatory practice. Overall, both the control of risk factors and the use of secondary prevention medications was suboptimal in these patients. However, those having consulted a cardiologist at any time during the previous year had better control of risk factors (and particularly LDL cholesterol and smoking) and were more often prescribed recommended secondary prevention medications.
Danchin
N
N
Clinique des maladies coronaires, HEGP, 20, rue Leblanc, 75015 Paris, France. nicolas.danchin@egp.ap-hop-paris.fr
Amelineau
E
E
Quentzel
S
S
Cambou
J P
JP
D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D008078:Cholesterol, LDL / Q000187:drug effects; D003324:Coronary Artery Disease / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005602:France; D019538:Health Care Surveys; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D010819:Physician's Role; D010818:Practice Patterns, Physicians'; D012307:Risk Factors; D016540:Smoking Cessation
D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents